Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Horizon Therapeutics (NQ: HZNP )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Horizon Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
New Analyses of the MIRROR Randomized Controlled Trial in Uncontrolled Gout Presented at the 2023 EULAR European Congress of Rheumatology
From Horizon Therapeutics plc
Via Business Wire
3 Stocks Worth Buying at 52-Week Lows
Here are three stocks that are trading near their 52-week lows and may be primed for a short-term rally for opportunistic investors 
Via MarketBeat
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Should Pfizer and Seagen investors be worried? 
Via The Motley Fool
Horizon Therapeutics plc Announces Presentation of Data that Advances the Understanding of Rheumatic Diseases at the 2023 EULAR European Congress of Rheumatology
From Horizon Therapeutics plc
Via Business Wire
A Look Into Horizon Therapeutics' Debt
Via Benzinga
Why Horizon Therapeutics Stock Is Crashing Today
The FTC is reportedly gearing up to block the drugmaker's takeover by Amgen. 
Via The Motley Fool
Stock Market Rally Hits 2023 Highs As Big Techs Lead; Tesla, Walmart, On Holding In Focus: Weekly Review
Chips, software and AI plays were strong. But leadership remains narrow. 
Via Investor's Business Daily
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?
Despite worries about FTC scrutiny, Pfizer remains optimistic about its planned Seagen acquisition, issuing $31 billion in bonds to finance the deal. 
Via MarketBeat
Topics Bonds
Exposures Debt Markets
The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach?
The FTC suit against Amgen appears to be a clear case of regulatory overreach but what this ultimately means will take time to fully develop. 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Horizon Therapeutics Unusual Options Activity For May 16
Via Benzinga
FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal
Pfizer Inc (NYSE: PFE) plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc (NASDAQ: SGEN)  
Via Benzinga
Horizon Therapeutics Options Trader Betting On A Major Dip For Stock By January 2024
Horizon Therapeutics Public Limited Company (NASDAQ: HZNP) shares dropped sharply on Tuesday following a report suggesting the FTC is expected to file a complaint to block Amgen's 
Via Benzinga
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?
Don't bank on the FTC winning in its attempt to stop Amgen's buyout of Horizon just yet. 
Via The Motley Fool
Is This Dow Jones Stock a Buy for Income Investors?
This pharmaceutical company is dedicated to maintaining its track record of innovation. 
Via The Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
The FTC's decision to sue to block a high-profile merger is weighing on biotech valuations today. 
Via The Motley Fool
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
In a rare move to block a large pharma deal, the U.S. 
Via Benzinga
Dow Down More Than 200 Points On Blue Chip Earnings
Stocks are all over the place midday. 
Via Talk Markets
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. 
Via Benzinga
Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday
Their declines weighed on the broader market. 
Via The Motley Fool
Horizon Therapeutics plc Responds to U.S. Federal Trade Commission (FTC) Action to Block Acquisition by Amgen
From Horizon Therapeutics plc
Via Business Wire
GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?
Gilead Sciences (GILD) stock is a hot topic on Tuesday as a new price target predicts a roughly 28% upside for the shares. 
Via InvestorPlace
Seagen (SGEN) Stock Falls 6% After Director Sells Shares
Seagen (SGEN) stock is slipping on Tuesday after one of the company's directors sold shares worth more than $372,000 on Monday. 
Via InvestorPlace
Former SVB CEO Blames Fed & Media Hype For Collapse, FTC Plans Lawsuit to Block Horizon Therapeutics $28B Takeover, Home Depot Lowers Annual Outlook: Today's Top Stories
Benzinga Former SVB Chief Blames Fed, Media Hype For Bank's Devastating Collapse 
Via Benzinga
HZNP Stock Alert: Why Is Horizon Therapeutics Plunging Today
Horizon Therapeutics (HZNP) stock is sinking after the FTC reportedly decided to sue to block its merger with Amgen (AMGN). 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Horizon Tumbles — Taking Seagen, Prometheus With It — On Reports FTC Could Block Its Amgen Takeover
Reports the FTC could block Amgen's takeover of Horizon reverberated across biotechs on Tuesday, with HZNP stock's crash leading the way. 
Via Investor's Business Daily
Why VirTra Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Gainers VivoPower International PLC (NASDAQ: VVPR) shares surged 88.3% to $0.8701 in pre-market trading as the company reported a definitive distribution agreement to distribute EV fleet charging... 
Via Benzinga
Amgen-Horizon Therapeutics Deal Regulatory Overhang: FTC Plans Lawsuit to Block $28B Takeover
The Federal Trade Commission is expected to file a lawsuit in a bid to block Amgen Inc's (NASDAQ: AMGN) $28 billion takeover of Horizon Therapeutics PLC (NASDAQ: HZNP). 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start off the day with a breakdown of all the biggest pre-market stock movers worth keeping an eye on Tuesday! 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.